Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute/Wake Forest School of Medicine, Charlotte, NC, USA.
Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Blood Cancer J. 2023 Dec 18;13(1):189. doi: 10.1038/s41408-023-00961-0.
There are significant disparities with regards to incidence, timely diagnosis, access to treatment, clinical trial participation and health care utilization that negatively impact outcomes for African American patients with multiple myeloma. Health care providers have a role in ameliorating these disparities with thoughtful consideration of historical, sociocultural, individual and disease characteristics that influence the care provided to African American patient population. This review by a group of experts committed to health disparity in multiple myeloma provides a snapshot of disparities at both biologic and non-biologic levels, barriers to clinical care, and best practices to ensure that African American patients receive the best care available.
在多发性骨髓瘤患者中,非裔美国人的发病情况、及时诊断、治疗机会、临床试验参与度和医疗保健利用率存在显著差异,这些差异对其预后产生负面影响。医疗保健提供者在为非裔美国患者提供护理时,应考虑到影响护理的历史、社会文化、个体和疾病特征,以减轻这些差异。一组致力于多发性骨髓瘤健康差异的专家对这些差异进行了综述,既包括生物和非生物层面的差异,也包括临床护理障碍以及确保非裔美国患者获得最佳治疗的最佳实践。